Literature DB >> 16924531

Release of band cells from the bone marrow is impaired by preoperative chemoradiation in patients with esophageal carcinoma: increased risk of postoperative pneumonia.

Tatsushi Suwa1, Yuko Kitagawa, Takahiro Sasaki, Tomoo Shatari, Masayoshi Sakuma, Masaki Kitajima.   

Abstract

PURPOSE: To examine the difference in hematological data and postsurgical course after esophagectomy between patients receiving preoperative chemoradiation and patients without preoperative treatment.
METHODS: Twenty-two patients with squamous cell carcinoma of the esophagus who underwent esophagectomy during the past 2 years were retrospectively analyzed in the study. Six patients had preoperative chemoradiation (CRT group) and 16 patients had no preoperative treatment (non-CRT group). The hematological data, postoperative course, and surgical complications were compared between the two groups.
RESULTS: Patients in the CRT group were given cisplatin and 5-FU (143 and 6,000 mg on average, respectively) plus an average of 35 Gy of radiation. Although the neutrophil count did not show a significant difference between the two groups, the band cell count was lower in the CRT group compared with the non-CRT group on postoperative day 1 (P<0.05). Postoperative pneumonia was detected in three patients (50%) from the CRT group versus none of the non-CRT group.
CONCLUSION: Preoperative CRT may be a risk factor for postoperative pneumonia in patients with esophageal carcinoma who undergo esophagectomy. The normal bone marrow response of releasing band cells from the postmitotic marrow pool after surgery could be disturbed by CRT, which might contribute to an increase in later pulmonary complications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16924531     DOI: 10.1007/s00423-006-0089-6

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  27 in total

1.  A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.

Authors:  John D Urschel; Hari Vasan
Journal:  Am J Surg       Date:  2003-06       Impact factor: 2.565

2.  Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma.

Authors:  T Noguchi; H Moriyama; S Wada; S Takeno; M Wakisaka; H Mori; Y Uchida
Journal:  Dis Esophagus       Date:  2003       Impact factor: 3.429

3.  Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma.

Authors:  J I Lew; W E Gooding; U Ribeiro; A V Safatle-Ribeiro; M C Posner
Journal:  Arch Surg       Date:  2001-07

4.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

Authors:  J F Bosset; M Gignoux; J P Triboulet; E Tiret; G Mantion; D Elias; P Lozach; J C Ollier; J J Pavy; M Mercier; T Sahmoud
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

5.  Analysis of reduced death and complication rates after esophageal resection.

Authors:  B P Whooley; S Law; S C Murthy; A Alexandrou; J Wong
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

6.  Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.

Authors:  Shu-lian Wang; Zhongxing Liao; Ara A Vaporciyan; Susan L Tucker; Helen Liu; Xiong Wei; Stephen Swisher; Jaffer A Ajani; James D Cox; Ritsuko Komaki
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-19       Impact factor: 7.038

7.  Bacteremic pneumococcal pneumonia: bone marrow release and pulmonary sequestration of neutrophils.

Authors:  Y Sato; S F van Eeden; D English; J C Hogg
Journal:  Crit Care Med       Date:  1998-03       Impact factor: 7.598

8.  Pulmonary complications after esophagectomy.

Authors:  Christopher E Avendano; Patrick A Flume; Gerard A Silvestri; Lydia B King; Carolyn E Reed
Journal:  Ann Thorac Surg       Date:  2002-03       Impact factor: 4.330

Review 9.  Multimodal treatment for squamous cell esophageal cancer.

Authors:  U Fink; H J Stein; H Wilke; J D Roder; J R Siewert
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 10.  Complications of salvage esophagectomy.

Authors:  John D Urschel; Frank W Sellke
Journal:  Med Sci Monit       Date:  2003-07
View more
  1 in total

1.  Increased platelet counts after transthoracic en bloc resection for esophageal cancer is associated with significantly improved survival.

Authors:  Frederike C Ling; Daniel Vallböhmer; Arnulf H Hoelscher; Daniel Schmidt; Elfriede Bollschweiler; Paul M Schneider
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.